• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment-refractory cutaneous Rosai-Dorfman disease responsive to oral methotrexate and topical trametinib.

作者信息

Fay Christopher J, Moslehi Dorsa, Iriarte Christopher, Dang Timothy M, Virgen Cesar A, Russell-Goldman Eleanor, LeBoeuf Nicole R

机构信息

Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.

Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

出版信息

JAAD Case Rep. 2023 Jul 7;39:74-77. doi: 10.1016/j.jdcr.2023.06.038. eCollection 2023 Sep.

DOI:10.1016/j.jdcr.2023.06.038
PMID:37650013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10462782/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441d/10462782/4aaa53946a35/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441d/10462782/fc084e8ab6ed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441d/10462782/a8e08ccd7f6f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441d/10462782/cab4a03adb79/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441d/10462782/4aaa53946a35/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441d/10462782/fc084e8ab6ed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441d/10462782/a8e08ccd7f6f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441d/10462782/cab4a03adb79/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441d/10462782/4aaa53946a35/gr4.jpg

相似文献

1
Treatment-refractory cutaneous Rosai-Dorfman disease responsive to oral methotrexate and topical trametinib.对口服甲氨蝶呤和外用曲美替尼有反应的难治性皮肤罗萨伊-多夫曼病
JAAD Case Rep. 2023 Jul 7;39:74-77. doi: 10.1016/j.jdcr.2023.06.038. eCollection 2023 Sep.
2
Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case.皮肤型罗萨伊-多夫曼病：1990年以来医学文献报道病例的综合回顾及1例典型病例展示
J Cutan Med Surg. 2006 Nov-Dec;10(6):281-90. doi: 10.2310/7750.2006.00067.
3
Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases.朗格汉斯细胞组织细胞增生症和罗-道氏病共存：两种组织细胞疾病在罕见情况下可能存在关联。
Mod Pathol. 2010 Dec;23(12):1616-23. doi: 10.1038/modpathol.2010.157. Epub 2010 Aug 20.
4
Emergence of cutaneous Rosai-Dorfman disease during immunosuppressive treatment of follicular B-cell lymphoma: A case report.滤泡性B细胞淋巴瘤免疫抑制治疗期间皮肤型罗萨伊-多夫曼病的出现：一例报告
SAGE Open Med Case Rep. 2021 Sep 16;9:2050313X211046455. doi: 10.1177/2050313X211046455. eCollection 2021.
5
A case of isolated cutaneous Rosai-Dorfman-Syndrome.一例孤立性皮肤型罗萨伊-多夫曼综合征。
Gulf J Oncolog. 2013 Jul;1(14):87-9.
6
A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib.一例携带MAP2K1致病变异的复发性组织细胞肉瘤患者接受MEK抑制剂曲美替尼治疗。
Int J Hematol. 2019 Feb;109(2):228-232. doi: 10.1007/s12185-018-2553-9. Epub 2018 Oct 25.
7
Refractory cutaneous Rosai-Dorfman disease responsive to cryotherapy.对冷冻疗法有反应的难治性皮肤罗萨伊-多夫曼病
Cutis. 2011 Jun;87(6):296-9.
8
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.成人组织细胞增生症的治疗要点：朗格汉斯细胞组织细胞增生症、 Erdheim-Chester 病、Rosai-Dorfman 病和噬血细胞性淋巴组织细胞增生症。
Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e66-e75. doi: 10.1016/j.clml.2020.08.007. Epub 2020 Aug 18.
9
Co-occurrence of intracranial Rosai-Dorfman disease and Langerhans histiocytosis of the skull: case report and review of literature.颅内罗萨伊-多夫曼病与颅骨朗格汉斯细胞组织细胞增多症并存：病例报告及文献复习
Turk Neurosurg. 2015;25(3):496-9. doi: 10.5137/1019-5149.JTN.10542-14.1.
10
Multiple Drug Regimen-Refractory Rosai-Dorfman-Destombes Disease Mimicking Relapsing Polychondritis Successfully Treated with Cobimetinib.多种药物治疗方案难治的罗萨伊-多夫曼-德斯顿贝斯病酷似复发性多软骨炎，用考比替尼成功治疗。
Eur J Case Rep Intern Med. 2022 Feb 4;9(2):003076. doi: 10.12890/2022_003076. eCollection 2022.

引用本文的文献

1
Cutaneous Rosai-Dorfman disease with near-complete response to the MEK inhibitor cobimetinib.皮肤型罗萨伊-多夫曼病对MEK抑制剂考比替尼近乎完全缓解。
JAAD Case Rep. 2025 Jul 17;64:53-56. doi: 10.1016/j.jdcr.2025.07.003. eCollection 2025 Oct.
2
Cutaneous Rosai-Dorfman Disease: A Report of 2 Cases and a Review of Recent Literature (2018-2023).皮肤型罗萨伊-多夫曼病：2例报告及近期文献综述（2018 - 2023年）
Case Rep Dermatol. 2025 Jun 23;17(1):204-223. doi: 10.1159/000546382. eCollection 2025 Jan-Dec.
3
Nasopharyngeal Representation of Rosai-Dorfman Disease; a Case Report.

本文引用的文献

1
Cutaneous Rosai Dorfman disease harboring RET and MAP2K1 mutations, successfully treated with methotrexate.携带RET和MAP2K1突变的皮肤型罗萨伊-多夫曼病，经甲氨蝶呤治疗成功。
Int J Dermatol. 2022 Nov;61(11):1409-1411. doi: 10.1111/ijd.16269. Epub 2022 May 15.
2
Rosai-Dorfman disease: an overview.罗萨达-多夫曼病：概述。
J Clin Pathol. 2020 Nov;73(11):697-705. doi: 10.1136/jclinpath-2020-206733. Epub 2020 Jun 26.
3
Cutaneous Rosai-Dorfman disease.皮肤型罗萨伊-多夫曼病
Rosai-Dorfman病的鼻咽部表现：一例报告
Indian J Otolaryngol Head Neck Surg. 2025 Apr;77(4):1871-1875. doi: 10.1007/s12070-025-05389-5. Epub 2025 Mar 6.
4
Rosai-Dorfman Disease, Presenting as a Right Atrial Mass with Involvement of the Tricuspid Valve in a 54-Year-Old Woman.罗塞-多夫曼病，表现为 54 岁女性右心房肿块并累及三尖瓣
Am J Case Rep. 2024 Mar 8;25:e942511. doi: 10.12659/AJCR.942511.
Cutis. 2019 Mar;103(3):171-173.
4
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.罗萨-多夫曼-德斯东贝病的诊断和临床管理共识建议。
Blood. 2018 Jun 28;131(26):2877-2890. doi: 10.1182/blood-2018-03-839753. Epub 2018 May 2.
5
Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms.组织细胞肿瘤中激酶改变的鉴定与靶向治疗
Hematol Oncol Clin North Am. 2017 Aug;31(4):705-719. doi: 10.1016/j.hoc.2017.04.008. Epub 2017 May 17.
6
Cutaneous Rosai-Dorfman Disease of the Face: A Comprehensive Literature Review and Case Report.面部皮肤型罗萨伊-多夫曼病：一项全面的文献综述及病例报告
J Oral Maxillofac Surg. 2016 Mar;74(3):528-40. doi: 10.1016/j.joms.2015.09.017. Epub 2015 Sep 25.
7
Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.低剂量甲氨蝶呤成功治疗皮肤型罗萨伊-多夫曼病。
JAMA Dermatol. 2014 Jul;150(7):787-8. doi: 10.1001/jamadermatol.2013.8679.
8
Rosai-Dorfman disease treated with methotrexate and low-dose prednisone: case report and review of the literature.Rosai-Dorfman 病经甲氨蝶呤和低剂量泼尼松治疗：病例报告及文献复习。
J Cutan Med Surg. 2012 Jul-Aug;16(4):281-5. doi: 10.1177/120347541201600411.
9
Cutaneous rosai-dorfman disease is a distinct clinical entity.皮肤型罗萨伊-多夫曼病是一种独特的临床实体。
Am J Dermatopathol. 2002 Oct;24(5):385-91. doi: 10.1097/00000372-200210000-00001.